Characterization of the K+ channel opening effect of the anticonvulsant retigabine in PC12 cells

Epilepsy Research

Volumn 35, Issue 2, 1999, Pages 99-107

  Rundfeldt, Chris ^a  

^a Arzneimittelwerk Dresden GmbH   (Germany)

Author keywords

Cortical neurones; Epilepsy pharmacology; Glial cells; Open rectifier; Patchclamp

Indexed keywords

4 AMINOPYRIDINE; BARIUM ION; DIMETHYL SULFOXIDE; NERVE GROWTH FACTOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; RETIGABINE; TETRYLAMMONIUM;

ANIMAL CELL; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN CORTEX; CELL STRAIN; CONTROLLED STUDY; ELECTRIC POTENTIAL; EPILEPSY; GLIA CELL; MEMBRANE CURRENT; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICONVULSANTS; CARBAMATES; CELLS, CULTURED; ELECTROPHYSIOLOGY; EPILEPSY; NERVE GROWTH FACTOR; PC12 CELLS; PHENYLENEDIAMINES; POTASSIUM CHANNELS; RATS;

EID: 0033011118     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(98)00131-4     Document Type: Article

References (48)

1. Anonymous, 1997. D-23129, Retigabine, Drugs Fut. 22, 1274-1275.
2. Beck H., Blumcke I., Kral T., Clusmann H., Schramm J., Wiestler O.D., Heinemann U., Elger C.E. Properties of a delayed rectifier potassium current in dentate granule cells isolated from the hippocampus of patients with chronic temporal lobe epilepsy. Epilepsia. 37:1996;892-901.
3. Chandy K.G., Gutman G.A. Voltage-gated potassium channel genes. North R.A. Handbook of Receptors and Channels. 1995;1-71 CRC Press, Boca Raton.
4. Charlier C., Singh N.A., Ryan S.G., Lewis T.B., Reus B.E., Leach R.J., Leppert M. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat. Genet. 18:1998;53-55.
5. + channel in rat PC12 cells by hypoxia. J. Physiol. Lond. 502:1997;293-305.
6. Dam M. Intractable epilepsy: introduction. Schmidt D., Morselli P.L. Intractable Epilepsy: Experimental and Clinical Aspects. 1986;1-3 Raven Press, New York, NY.
7. Dailey J.W., Cheong J.H., Ko K.H., Adams-Curtis L.E., Jobe P.C. Anticonvulsant properties of D-20443 in genetically epilepsy-prone rats: prediction of clinical response. Neurosci. Lett. 195:1995;77-80.
8. Doupnik C.A., Davidson N., Lester H.A. The inward rectifier potassium channel family. Curr. Opin. Neurobiol. 5:1995;268-277.
9. + channel openers decrease seizures in genetically epileptic rats. Eur. J. Pharmacol. 167:1989;181-183.
10. Garber S.S., Hoshi T., Aldrich R.W. Regulation of ionic currents in pheochromocytoma cells by nerve growth factor and dexamethasone. J. Neurosci. 9:1989;3976-3987.
11. Goldstein S.A., Price L.A., Rosenthal D.N., Pausch M.H. ORK1, a potassium-selective leak channel with two pore domains cloned from Drosophila melanogaster by expression in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA. 93:1996;13256-13261.
12. Grene L.A., Tischler A.S. PC12 pheochromocytoma cultures in neurobiological reseach. Adv. Cell Neurobiol. 3:1982;373-414.
13. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391:1981;85-100.
14. Hille, B., 1993. Ionic Channels of Excitable Membranes, 2nd ed. Sinauer, Sunderland, MA.
15. Hu Q., Shi Y.L. Characterization of an inward-rectifying potassium current in NG108-15 neuroblastoma x glioma cells. Pflügers Arch. 433:1997;617-625.
16. + uptake in glia prevents long-term depression maintenance and causes epileptiform activity. J. Neurosci. 17:1997;2813-2824.
17. + current in undifferentiated and NGF-treated PC12 cell variants. Neuroreport. 8:1997;1369-1374.
18. Kapetanovic I.M., Yonekawa W.D., Kupferberg H.J. The effects of D-23129, a new experimental anticonvulsant drug, on neurotransmitter amino acids in the rat hippocampus in vitro. Epilepsy Res. 22:1995;167-173.
19. Kapetanovic I.M., Rundfeldt C. D-23129: a new anticonvulsant compound. CNS Drug Rev. 2:1996;308-321.
20. Ketchum K.A., Joiner W.J., Sellers A.J., Kaczmarek L.K., Goldstein S.A. A new family of outwardly rectifying potassium channel proteins with two pore domains in tandem. Nature. 376:1995;690-695.
21. Kettenmann H., Ransom B.R. Neuroglia. 1995;Oxford University Press, New York/Oxford.
22. Kirkby R.D., Johns D.C., Marban E., Lawrence J.H., Rogawski M.A. Adenovirus encoding a voltage-gated potassium channel attenuates picrotoxin-induced hippocampal epileptiform discharge in vivo. Soc. Neurosci. Abstr. 22:1996;2086.
23. Lazdunski, M. 1996. Unpublished observations.
24. + channel with a novel structure. EMBO J. 15:1996;1004-1011.
25. Leonoudakis D., Gray A.T., Winegar B.D., Kindler C.H., Harada M., Taylor D.M., Chavez R.A., Forsayeth J.R., Yost C.S. An open rectifier potassium channel with two pore domains in tandem cloned from rat cerebellum. J. Neurosci. 18:1998;868-877.
26. Loiseau P. Do we need novel anti-epileptic drugs? Br. J. Clin. Pract. 42:1988;2-3.
27. Lopatin A.N., Makhina E.N., Nichols C.G. Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification. Nature. 372:1994;366-369.
28. Meldrum B.S. Identification and preclinical testing of novel antiepileptic compounds. Epilepsia. 38(Suppl 9):1997;S7-15.
29. Nichols C.G., Lopatin A.N. Inward rectifier potassium channels. Annu. Rev. Physiol. 59:1997;171-191.
30. Patil N., Cox D.R., Bhat D., Faham M., Myers R.M., Peterson A.S. A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation. Nat. Genet. 11:1995;126-129.
31. Pechstein, B., Hermann, R., Terhaag, B., 1996. Tolerability, pharmacokinetics and dose linearity of D-23129 following oral single dose escalation in healthy volunteers. Naunyn. Schmied. Arch. Pharmacol. 354 (Suppl. 1), Abst. 124.
32. Pollok J.D., Krempin M., Rudy B. Differential effects of NGF, FGF, cAMP, and dexamethasone on neurite outgrowth and sodium channel expression in PC12 cells. J. Neurosci. 10:1990;2626-2637.
33. + channel pharmacology. Trends Pharmacol. Sci. 13:1992;359-365.
34. Popoli P., Pezzola A., Sagratella S., Zeng Y.C., Scotti de Carolis A. Cromakalim (BRL 34915) counteracts the epileptiform activity elicited by diltiazem and verapamil in rats. Br. J. Pharmacol. 104:1991;907-913.
35. Porter R.J. Classification of epileptic seizures and epileptic syndromes. Laidlaw J., Richens A., Chadwick D. A Textbook of Epilepsy. 1993;1-22 Churchill Livingstone, New York.
36. Reuter H., Bouron A., Neuhaus R., Becker C., Reber B.F.X. Inhibition of protein kinases in rat pheochromocytoma (PC12) cells promotes morphological differentiation and down-regulates ion channel expression. Proc. R. Soc. Lond. B. Biol. Sci. 249:1992;211-216.
37. Rostock A., Tober C., Rundfeldt C., Bartsch R., Engel J., Polymeropoulos E.E., Kutscher B., Löscher W., Hönack D., White H.S., Wolf H.H. D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Res. 23:1996;211-223.
38. Rudy B. Diversity and ubiquity of potassium channels. Neuroscience. 25:1988;729-749.
39. Rundfeldt C., Rohlfs A., Netzer R. Multiple actions of the new anticonvulsant D-23129 on voltage-gated inward currents and GABA-induced currents in cultured neuronal cells. Naunyn Schmiedeb. Arch. Pharmacol. 351:1995;R160.
40. + channels in neuronal cells. Eur. J. Pharmacol. 336:1997;243-249.
41. Rundfeldt C., Dost R. The potassium channel opening property of the new anticonvulsant D-23129 is selective for neuronal cells. Naunyn-Schmiedeb. Arch. Pharmacol. 355(Suppl. 4):1997;R91.
42. Schmidt D. Anticonvulsants. Duke M.N.G. Meyler's Side Effects of Drugs. 12th Ed. 1992;122-143 Elsevier Science Publisher, Amsterdam.
43. + channels in PC12 cells. J. Cell. Biol. 123:1993;1835-1843.
44. + currents in neurones: types, physiological roles and modulation. Trends Neurosci. 19:1996;150-154.
45. Tober C., Rostock A., Rundfeldt C., Bartsch R. D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures. Eur. J. Pharmacol. 303:1996;163-169.
46. 2+ channels in rat pheochromocytoma cell lines. J. Physiol. Lond. 426:1990;95-116.
47. Wei A., Jegla T., Salkoff L. Eight potassium channel families revealed by the C. elegans genome project. Neuropharmacology. 35:1996;805-829.
48. Weston A.H., Edwards G. Recent progress in potassium channel opener pharmacology. Biochem. Pharmacol. 43:1992;47-54.